Shigemi Matsuyama

Shigemi Matsuyama, DVM, PhD is a Professor at Case Western Reserve University School of Medicine, with primary appointment in the Department of Ophthalmology and Visual Sciences and secondary appointments in Pharmacology, Pathology, Medicine (Hematology and Oncology), General Medical Sciences, and the Case Comprehensive Cancer Center.

• Education:
  • BSc, University of Tokyo
  • Doctor of Veterinary Medicine, University of Tokyo
  • PhD, University of Tokyo
  • Postdoctoral Training: The Burnham Institute (La Jolla Cancer Research Foundation)

Research Interests focus on:

• Mechanisms of mitochondria-dependent cell death regulation
• Epigenetic aging and DNA methylation age
• Development of small compounds to inhibit cell death
• Age-associated diseases and inherited retinal dystrophies
• Age-dependent corneal endothelial dystrophy

Key Scientific Awards:

• Translational Research Acceleration Award (2024, Foundation Fighting Blindness)
• Edmond S. Ricanati, MD Award (2020, Case Western Reserve University)
• Gund-Harrington Scholar Award (2017, Foundation Fighting Blindness)
• ASH Scholar Award (2002, American Society of Hematology)
• Intergen Young Investigator Award (2000, American Association of Cancer Research)
• Bristol-Myers Squibb Young Investigator Award (1999, American Association of Cancer Research)
• Veterinary Medical Science Scholar Award (1994, Japanese Society of Veterinary Science)
• Kato Memorial Award for Biological Research (1992, Kato Memorial Foundation)

Professional Memberships:

• Council Member, Society of Experimental Biology and Medicine
• Member, Association of Research in Vision and Ophthalmology
• Member, International Society of Eye Research
• Member, American Society of Hematology
• Member, American Association of Cancer Research

Editorial Roles:

• Associate Editor (Aging Section), Experimental Biology and Medicine
• Section Editor (Cancer Research), Science Progress
• Editorial Board Member (Cell Biology Section), Cells